Juul Settles with Iowa Over Underage Marketing

Dec.29.2022
Juul Settles with Iowa Over Underage Marketing
Juul, a major US e-cigarette manufacturer, will pay $5m and improve its advertising to settle claims of targeting minors in Iowa.

Juul, the largest electronic cigarette manufacturer in the United States, has agreed to improve its advertising and retail practices in Iowa and pay $5 million over the course of four years to resolve allegations of violating state laws.


Iowa's Attorney General Tom Miller announced a settlement with Juul to resolve potential violations of Iowa's Deceptive Trade Practices Act.


Miller claims that targeting individuals under the age of 21 in Iowa is a violation of state law, and is a focus of their company's products.


In a statement, Miller said, "The agreement strikes a balance in the truthful advertising and promotion of Juul e-cigarette devices and pods. E-cigarettes should be marketed to smokers as a less harmful alternative, but not to young people.


As part of an agreement, Juul has agreed to annually send $1.25 million to the Iowa Department of Public Health. The funds will be used to provide resources and education to youth under the age of 21 in Iowa, including assistance with smoking cessation.


The company denies any wrongdoing and additionally agrees to: [insert other terms here].


Do not target young people in Iowa through advertising, promotions, or marketing of Juul products.


Individuals are required to conduct age verification on any website they own or operate.


Do not display Juul products in retail stores outside of the counter area, and customers are not allowed to access the products with the assistance of employees.


Online transactions will be limited to a maximum of two Juul devices per month, ten Juul devices per year, and 60 Juul pods per month.


Taking reasonable measures, retail transactions in Iowa are limited to one Juul device or 16 Juul pods per transaction.


Do not sell products to consumers under the age of 21.


Disclose the nicotine content in their products.


The company has also agreed to appoint a designated staff member to ensure compliance with the agreement with the Iowa Attorney General's office and to address any compliance-related issues.


In 2018, Juul Labs sought guidance from Miller on using their product as a means to reach young people. Miller was employed as part of these efforts.


In April 2018, this electronic cigarette manufacturer announced that, as part of a $30 million initiative over the next three years, it will support efforts by states and the federal government to raise the minimum age for purchasing tobacco products. The initiative amounts to approximately 210 million yuan.


Part of the funding includes a research team led by former Attorney General and public health officials, convened by Miller, who has ties to the tobacco industry.


A spokesperson for the Office of the Attorney General stated, "The consulting group was independent from Juul, and its members did not receive any form of compensation. The group's recommendations to Juul were similar to the final settlement agreement. The consulting group disbanded at the end of 2018.


In 1998, Miller and other 45 state attorneys general signed a settlement agreement with the four major tobacco companies in the United States to resolve lawsuits related to state healthcare costs associated with smoking-related illnesses.


This agreement is the largest of its kind in American history, requiring companies to pay $206 billion over 25 years to 46 states, followed by annual payments based on national cigarette sales.


Over the past 24 years, the state has received more than $1.41 billion (approximately RMB 9.84 billion) in payments as part of the peace agreement.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

FDA Unifies Tobacco Registration and Product Listing Form Across Product Categories
FDA Unifies Tobacco Registration and Product Listing Form Across Product Categories
The U.S. FDA has consolidated two tobacco establishment registration and product listing forms into a redesigned Form FDA 3741 covering all regulated product categories, including e-cigarettes, heated tobacco products and nicotine pouches. The current requirements remain limited to domestic establishments. Separately, the FDA has proposed extending registration and product listing requirements to foreign manufacturers, signaling greater regulatory attention to manufacturing entities and product-level information across the tobacco and nicotine supply chain.
FDA
Sep.30
Kumulus Vape2026 H1 Revenue Falls 8.3% but Profit Rises 24% as B2B Weakens and Consumer Channels Grow
Kumulus Vape2026 H1 Revenue Falls 8.3% but Profit Rises 24% as B2B Weakens and Consumer Channels Grow
French vaping company Kumulus Vape reported first-half 2026 revenue of €25.5 million, down 8.3% year over year, as its core B2B distribution business fell 11% to €21.6 million. B2C and store-network revenue rose 5.6% and 17.8%, respectively. Commercial margin increased to 26.3% from 21.7%, while net profit rose 24.1% to €0.8 million. The company attributed the profitability improvement to catalog optimization, logistics restructuring and the ramp-up of Labster, its in-house production unit for proprietary brands.
Market
Sep.17 by 2Firsts Perspectives
Product | KUMI SCENIC 50K Offers Nicotine and 6-Methyl Nicotine Versions as 6-MN Products Appear in Multiple U.S. State Directories, With Louisiana Listing FDA Exemption
Product | KUMI SCENIC 50K Offers Nicotine and 6-Methyl Nicotine Versions as 6-MN Products Appear in Multiple U.S. State Directories, With Louisiana Listing FDA Exemption
An October 2026 review of U.S. state vapor product directories found KUMI 6 SCENIC 50K listed in Louisiana and Nebraska. Louisiana classifies 20 related product entries as “FDA EXEMPTION.” The SCENIC platform is marketed in both conventional nicotine-salt and NoNic6 formulations, each advertised with 22mL e-liquid capacity and up to 50,000 puffs. U.S. wholesaler Midwest Goods listed both versions in August 2025 with a suggested retail price of $19.99 each. The NoNic6 version is associated with 6-methylnicotine and is also marketed by some distributors as “nicotine-free.”
product
Oct.27
Italy Proposes Earlier Vape and HTP Tax Hikes, New Rules for E-Liquid Pricing, Exclusive Deals and Distribution
Italy Proposes Earlier Vape and HTP Tax Hikes, New Rules for E-Liquid Pricing, Exclusive Deals and Distribution
Italy's proposed 2027–2029 budget would bring forward scheduled tax increases for e-cigarette liquids and heated tobacco products from January 1, 2028, to July 1, 2027. The consumption tax coefficient for nicotine-containing e-liquids would rise from 20% to 22%, that for nicotine-free liquids and applicable flavorings from 15% to 17%, and the heated-tobacco coefficient from 41% to 42%. The bill would also introduce official retail price schedules for e-liquids, restrict exclusive agreements between retailers and suppliers, and limit single-brand-dominated displays, sales incentives and bundled offers. Importing, authorized warehousing and retailer sourcing arrangements would also change. The proposals remain subject to parliamentary approval and subsequent implementing regulations.
Regulations
Nov.04
German Customs Seize 115,800 Vapes in €1.4 Million Tax Case
German Customs Seize 115,800 Vapes in €1.4 Million Tax Case
Germany's Magdeburg Main Customs Office seized 115,800 untaxed e-cigarettes containing a combined 4.366 million mL of e-liquid during four truck inspections between August 10 and September 4, 2026. The seizures prevented an estimated €1.397 million in tax losses and set a record for the customs office's jurisdiction. Criminal proceedings have been initiated against four truck drivers. The case follows a separate German investigation involving more than 7.6 million illicit vapes and an estimated €33.3 million in excise-tax losses.
Enforcement
Oct.13
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
A commentary published in the international open-access, peer-reviewed Harm Reduction Journal argues that randomized controlled trials remain central to evaluating smoking cessation efficacy but cannot alone capture real-world uptake, complete switching, longer-term use and population impact of non-combustible nicotine products such as e-cigarettes, heated tobacco and nicotine pouches. The authors frame impact as “reach × efficacy” and call for real-world evidence to complement RCTs. Three days after publication, the FDA authorized three JUUL2 products and highlighted complete switching among adult smokers in explaining its decision, providing a timely regulatory backdrop to the debate.
Sep.08